reports
Indkaldelse til ordinær generalforsamling i BioPorto A/S
Indkaldelse til ordinær generalforsamling i BioPorto A/S 26. marts 2026Selskabsmeddelelse nr. 5 Indkaldelse til ordinær generalforsamling i BioPorto A/S Bestyrelsen indkalder hermed til ordinær generalforsamling i BioPorto A/S ("BioPorto" eller "Selskabet"), som afholdes: 24. april 2026 kl. 15.00på Selskabets adresseTuborg Havnevej 15, st., 2900 Hellerup, Danmark DAGSORDEN: PUNKT 1 - BERETNING OM SELSKABETS VIRKSOMHED I DET FORLØBNE ÅR Bestyrelsen foreslår, at bestyrelsens beretning om Selskabets virksomhed i det forløbne år tages til efterretning. PUNKT 2 – FREMLÆGGELSE AF ÅRSRAPP...
Notice convening the Annual General Meeting in BioPorto A/S
Notice convening the Annual General Meeting in BioPorto A/S 26 March 2026Announcement no. 5 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S (“BioPorto” or the “Company”) to be held on: 24 April 2026 at 3.00 p.m. (CEST)at the Company’s addressTuborg Havnevej 15, st., DK-2900 Hellerup, Denmark AGENDA: ITEM 1 - REPORT ON THE COMPANY’S ACTIVITIES DURING THE PAST YEAR The Board of Directors proposes that the Board's report on the Company’s activities for the past year be noted. ITEM 2 – PRESENT...
BioPorto annoncerer Årsrapporten for 2025
BioPorto annoncerer Årsrapporten for 2025 26. marts 2026Meddelelse nr. 04 BioPorto annoncerer årsrapporten for 2025 København, Danmark, 26. marts 2026 (GLOBE NEWSWIRE) – BioPorto A/S CVR-nr. 17500317 (BioPorto eller selskab) (CPH:BIOPOR) offentliggjorde i dag de finansielle resultater for året 2025. De finansielle resultater for 2025 bekræfter de foreløbige, ureviderede finansielle tal for 202...
BioPorto announces the Annual Report for 2025
BioPorto announces the Annual Report for 2025 March 26, 2026Announcement no. 04 BioPorto announces the Annual Report for 2025 Copenhagen, Denmark, March 26, 2026, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or company) (CPH:BIOPOR), today announced the annual financial results for 2025. The financial results for 2025 confirm the preliminary unaudited 2025 financial figures released Fe...
BioPorto gennemfører succesfuld foreløbig analyse af det amerikanske v...
BioPorto gennemfører succesfuld foreløbig analyse af det amerikanske voksne NGAL-cutoff-studie; Pre-submission forventes indsendt inden udgangen af første kvartal 2026 18. marts, 2026Meddelelse no. 03 BioPorto gennemfører succesfuld foreløbig analyse af det amerikanske voksne NGAL-cutoff-studie; Pre-submission forventes indsendt inden udgangen af første kvartal 2026 KØBENHAVN, DANMARK, 18. marts, 2026 – BioPorto A/S (“BioPorto” eller “Selskabet”) (CPH: BIOPOR) offentliggør i dag en positiv klinisk opdatering baseret på den foreløbige analyse af selskabets amerikanske NGAL‑cutoff‑studie i...
BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGA...
BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 March 18, 2026Announcement no. 03 BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 COPENHAGEN, DENMARK, March 18, 2026 – BioPorto A/S (“BioPorto” or “Company”) (CPH: BIOPOR) today announced positive clinical readout update of the preliminary analysis of its U.S. adult NGAL Cutoff Study, designed to evaluate the clinical performance of NGAL in assessing risk of acute kidney injury (AKI...
BioPorto A/S udnævner CFO
BioPorto A/S udnævner CFO 9. februar, 2026Meddelelse nr. 2 BioPorto A/S udnævner CFO BioPorto A/S (BioPorto) (CPH:BIOPOR) annoncerede i dag udnævnelsen af Klaus Juhl Wulff som ny Executive Vice President (EVP) og Chief Financial Officer (CFO) samt medlem af Executive Management-teamet senest pr. 1. maj 2026. Klaus Juhl Wulff er en højt kvalificeret leder med mere end 20 års erfaring inden for finans, drift, M&A og kapitalmarkeder. Han kommer til BioPorto fra AquaPorin A/S, hvor han var CFO fra 2022. Før dette har Klaus Juhl Wulff fungeret som CFO i forskellige virksomheder. Klaus Juhl W...
BioPorto A/S Appoints Chief Financial Officer
BioPorto A/S Appoints Chief Financial Officer February 9, 2026Announcement no. 2 BioPorto A/S Appoints Chief Financial Officer BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced the appointment of Klaus Juhl Wulff as its new Executive Vice President (EVP) and Chief Financial Officer (CFO), and member of the Executive Management team as of latest May 1st, 2026. Klaus Juhl Wulff is a highly skilled leader with more than 20 years of experience in finance, operations, M&A and capital markets. He joins BioPorto from AquaPorin A/S, where he served as CFO from 2022. Prior to this, Klaus Juhl...
BioPorto leverer foreløbige, ureviderede finansielle tal for 2025, fin...
BioPorto leverer foreløbige, ureviderede finansielle tal for 2025, finansiel guidance for 2026 og en forretningsopdatering 5. februar 2026Meddelelse nr. 1 BioPorto leverer foreløbige, ureviderede finansielle tal for 2025, finansiel guidance for 2026 og en forretningsopdatering KØBENHAVN, DANMARK, 5. februar, 2026, (GLOBE NEWSWIRE) – BioPorto A/S CVR-nr. 17500317 (BioPorto eller Selskabet) (CPH:BIOPOR), annoncerede i dag foreløbige, ureviderede finansielle tal for 2025, finansiel guidance for 2026 og en forretningsopd...
BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financ...
BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update February 5, 2026Announcement no. 1 BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update COPENHAGEN, DENMARK, February 5, 2026, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or Company) (CPH:BIOPOR), today announced Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a business update. ...
Ændringer i selskabets Direktion
Ændringer i selskabets Direktion 11. december 2025 Meddelelse nr. 29 Ændringer i selskabets Direktion KØBENHAVN, DANMARK og BOSTON, MA, USA, 11. december 2025 (GLOBE NEWSWIRE) – BioPorto A/S ("BioPorto") (CPH:BIOPOR) meddelte i dag, at Niels Høy Nielsen har opsagt sin stilling som CFO for BioPorto for at tiltræde en CFO-stilling i et andet selskab. "Jeg har værdsat det tætte samarbejde med Niels i de sidste par måneder, siden jeg tiltrådte min stilling i BioPorto. Niels har ydet vigtige bidrag til virksomheden og jeg ønsker ham alt det bedste i hans fremtidige stilling," sagde Carsten B...
Changes to the Executive Management
Changes to the Executive Management December 11, 2025 Announcement no. 29 Changes to the Executive Management COPENHAGEN, DENMARK and BOSTON, MA, USA, December 11, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto”) (CPH:BIOPOR) announced today that Niels Høy Nielsen has resigned as CFO of BioPorto to become CFO at another company. “I have valued the close collaboration with Niels during the last couple of months since I joined BioPorto. He has made important contributions across the company and wish him all the bes...
Ledende medarbejderes transaktioner
Ledende medarbejderes transaktioner 24. november 2025Meddelelse nr. 28 Ledende medarbejderes transaktioner I forbindelse med gennemførelsen af BioPorto A/S' rettede emission, som beskrevet i selskabsmeddelelse nr. 27, har BioPorto A/S i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget indberetning af nedenstående transaktioner vedrørende aktier i BioPorto A/S foretaget af personer med ledelsesansvar i BioPorto A/S og/eller nærtstående til disse. 1 Nærmere oplysninger om personen med ledelsesansvar/pers...
Managers’ transactions
Managers’ transactions November 24, 2025Announcement no. 28 Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 27, BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely associated with them. 1 Details of the person discharging managerial responsi...
BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i anta...
BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer 24. november 2025 Meddelelse nr. 27 BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer Gennemførelse af kapitalforhøjelse København, Danmark, 24. november 2025, (GLOBE NEWSWIRE) - Bestyrelsen for BioPorto A/S ("BioPorto" eller "Selskabet") (CPH:BIOPOR) besluttede den 13. november 2025 at gennemføre en rettet emission af 40.438.426 nye aktier til eksisterende større aktionærer, nye instit...
BioPorto A/S raises approximately DKK 43 million in new capital round ...
BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes 24 November 2025 Announcement no. 27 BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes Completion of share capital increase COPENHAGEN, DENMARK, 24 November 2025 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), decided on 13 November 2025, to complete a private placement of 40,438,426 new shares t...
BioPortos delårsresultat for tredje kvartal 2025 – Fortsat fremdrift o...
BioPortos delårsresultat for tredje kvartal 2025 – Fortsat fremdrift og fortsat øget NGAL-salgsvækst 19. november 2025 Meddelelse nr. 26 BioPortos delårsresultat for tredje kvartal 2025 – Fortsat fremdrift og fortsat øget NGAL-salgsvækst København, Danmark, 19. november 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller Selskabet) (CPH:BIOPOR) annoncerede i dag delårsresultatet for tredje kvartal 2025, som er uæ...
BioPorto Interim Result for the Third Quarter of 2025 – Continued prog...
BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth. Copenhagen, Denmark, November 19, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), today announced interim financial results for the third quarter of 2025, unchanged from the pre-announced Key Financial Results that were announced on November 4, 2025. Highlights of key strategic milestones and a renewed...
Rettet emission af 40.438.426 nye aktier fuldt tegnet – bruttoprovenu ...
Rettet emission af 40.438.426 nye aktier fuldt tegnet – bruttoprovenu på cirka 43 mio. kr. til BioPorto A/S 13. november 2025 Meddelelse nr. 25 Rettet emission af 40.438.426 nye aktier fuldt tegnet – bruttoprovenu på cirka 43 mio. kr. til BioPorto A/S København, Danmark, 13. november 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller Selskabet) (CPH:BIOPOR) meddeler, at en rettet emission af 40.438.426 nye aktier er blevet gennemført. Iværksættelsen af den rettede emission blev annonceret i selskabsmeddelelse nr...
Private placement of 40,438,426 new shares fully subscribed – gross pr...
Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S 13 November 2025 Announcement no. 25 Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S Copenhagen, Denmark, 13 November 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), announces that the private placement of 40,438,426 new shares has been completed. The initiation of the private placem...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.